Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: brain atrophy (Click to remove) Alemtuzumab CARE-MS I 5-year follow-up Neurol 89:1107-1116, Havrdova, E.,et al, 2017 Alemtuzumab CARE-MS II 5-year follow-up Neurol 89:1117-1126, Coles, A.J.,et al, 2017 The Syndrome of Cutaneous Photosensitivity, Growth Failure, and Basal Ganglia Calcification Neurol 87:e56-e57, Saini, A.G.,et al, 2016 Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial Lancet 383:2213-2221, Chataway, J.,et al, 2014 Neurological Manifestation of Recreational Fatal and Near-Fatal Diethylene Glycol Poisonings Medicine 93:e62, Imam, Y.Z.B.,et al, 2014 Sturge-Weber Syndrome UptoDate , Nov, Bodensteiner, J.B., 2014 Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens JNNP 84:748-755, Hacohen, Y.,et al, 2013 Sturge-Weber Syndrome MedLink Neurology, July, Comi, A.M., 2013 Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012 Resuscitating the Heart but Losing the Brain: Brain Atrophy in the Aftermath of Cardiac Arrest Neurol 74:306-312, Horstmann,A.,et al, 2010 Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis JNNP 73:141-147, Dalton,C.M.,et al, 2002 Clinicopath Conf, Neuronal Ceroid Lipofuscinosis, Late-Onset Infantile Subtype NEJM 347:672-680, Case 27-2002, 2002 Showing articles 0 to 12 of 12